Ocular Therapeutix, Inc. (OCUL) Insider Trading

Over the last 3 months, OCUL insiders made 0 open-market buys and 4 sales, a net sale of -$238K (SEC Form 4). Over the last 6 months, 221 institutions increased and 122 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
4
Net (3m)
-$237.8K
Insider trades by month Buys Sells
Aug
Sep
Oct
Nov
Feb
May
Context3-month price -24.4%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 28, 2026Kaiser Peterofficer: Chief Development OfficerSell2,967$8.20
May 28, 2026Heier Jeffrey S.officer: Chief Scientific OfficerSell3,018$8.20
May 28, 2026Nayak Sanjayofficer: Chief Strategy OfficerSell1,858$8.20
May 28, 2026Dugel Pravindirector, officer: See RemarksSell21,156$8.20
Feb 25, 2026Kaiser Peterofficer: Chief Development OfficerSell2,810$8.28
Feb 25, 2026Heier Jeffrey S.officer: Chief Scientific OfficerSell3,057$8.28
Feb 25, 2026Nayak Sanjayofficer: Chief Strategy OfficerSell1,759$8.28
Feb 25, 2026Dugel Pravindirector, officer: See RemarksSell20,056$8.28
Feb 24, 2026Waheed Nadiaofficer: Chief Medical OfficerSell3,510$7.74
Feb 24, 2026LINDSTROM RICHARD L MDdirectorBuy60,229$7.66
Feb 17, 2026Notman Donaldofficer: Chief Operating OfficerSell11,446$9.04
Feb 17, 2026Nayak Sanjayofficer: Chief Strategy OfficerSell10,348$9.04
Feb 17, 2026Dugel Pravindirector, officer: See RemarksSell124,882$9.04
Feb 17, 2026Waheed Nadiaofficer: Chief Medical OfficerSell7,863$9.04
Feb 4, 2026Notman Donaldofficer: Chief Operating OfficerSell5,455$9.14
Feb 4, 2026Notman Donaldofficer: Chief Operating OfficerSell6,035$8.54
Jan 26, 2026Robinson David Wayneofficer: Global CCOGrant136,000
Jan 26, 2026Robinson David Wayneofficer: Global CCOGrant416,000$11.42
Jan 22, 2026Robins Jason Shandofficer: Interim CFOGrant33,000$11.45
Jan 6, 2026Anderman Toddofficer: Chief Legal OfficerGrant197,650$11.82
Jan 6, 2026Anderman Toddofficer: Chief Legal OfficerGrant64,900
Jan 6, 2026Nayak Sanjayofficer: Chief Strategy OfficerGrant197,650$11.82
Jan 6, 2026Kaiser Peterofficer: Chief Development OfficerGrant79,112
Jan 6, 2026Kaiser Peterofficer: Chief Development OfficerGrant240,932$11.82
Jan 6, 2026Saroj Namrataofficer: Chief Business OfficerGrant79,112
Jan 6, 2026Saroj Namrataofficer: Chief Business OfficerGrant240,932$11.82
Jan 6, 2026Waheed Nadiaofficer: Chief Medical OfficerGrant79,112
Jan 6, 2026Waheed Nadiaofficer: Chief Medical OfficerGrant240,932$11.82
Jan 6, 2026Heier Jeffrey S.officer: Chief Scientific OfficerGrant79,112
Jan 6, 2026Heier Jeffrey S.officer: Chief Scientific OfficerGrant240,932$11.82

Source: OCUL SEC Form 4 filings, latest May 28, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their OCUL positions over the last 6 months (SEC Form 13F).

Increased
221
New positions
130
Reduced
122
Sold out
69
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased32.7MMay 15, 2026
FMR LLCReduced31.8MFeb 17, 2026
DEEP TRACK CAPITAL, LPIncreased19.7MMay 15, 2026
BLACKROCK, INC.Increased16.1MMay 13, 2026
BLACKROCK, INC.Increased15.6MFeb 12, 2026
AVORO CAPITAL ADVISORS LLCIncreased12.3MMay 15, 2026
SUMMER ROAD LLCIncreased11.9MApr 23, 2026
VANGUARD GROUP INCIncreased11.6MJan 29, 2026
SUMMER ROAD LLCReduced11.1MFeb 11, 2026
AVORO CAPITAL ADVISORS LLCIncreased10.8MMar 16, 2026
VR ADVISER, LLCIncreased10.3MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position8.7MMay 15, 2026
DEEP TRACK CAPITAL, LPReduced8.1MFeb 13, 2026
VR ADVISER, LLCReduced7.3MFeb 17, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased5.9MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.